The Use of Educational Technology in Improving Adherence Therapy
HYPERTENSIVE PATIENT ADHERENCE TO TREATMENT: THE USE OF THERAPEUTIC COMMUNICATION ASSOCIATED WITH TECHNOLOGY EDUCATIONAL IN HEALTH PROMOTION"
2 other identifiers
interventional
57
0 countries
N/A
Brief Summary
Few studies show the benefits of educational technologies a support for the control of chronic diseases. The approach known as 'embracement' adopts relational strategies or soft technologies which promote bonding and may impact therapy adherence and quality of life in hypertensive patients.Objectives:To assess the impact of the embracement approach on therapy adherence, quality of life, and the white coat effect in hypertensive outpatients followed in a specialized clinic. This approach may be associated or not with the use of educational technology in a virtual learning environment(VLE) for distance learning (DL) and with use the educational technology in Blended E-learning (E-BLENDED)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2013
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 18, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 25, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
February 17, 2017
CompletedFirst Submitted
Initial submission to the registry
June 5, 2017
CompletedFirst Posted
Study publicly available on registry
October 27, 2017
CompletedOctober 27, 2017
October 1, 2017
1.4 years
June 5, 2017
October 26, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
measure blood arterial pressure
At the first nurse interview (day 0: randomization), a questionnaire was used to obtain information related to general data, habits, history of disease, other risk factors for cardiovascular disease, and prescribed medications. This questionnaire was used only to characterize the adherence behavior and the risk factors at the beginning the study, but was not used to evaluate modifications of behavior during the study. Body weight and height were measured. Three consecutive measurements of BP were taken after the patient had rested for 5 min in the supine position.
4 months
Ambulatory Blood Pressure monitoring
Ambulatory BP monitoring was recorded at day ) in randomization and 120 days of follow-up for 24 h with a noninvasive ABPM (Space Labs 90207 monitor; Space Labs, Redmond, WA) with an appropriate-sized cuff. The monitor was placed on the nondominant arm and was set to take BP readings every 10 min during the day and every 20 min at nigh
4 months
Pill count
count of the compliments dispensed by the pharmacy and count of the empty blisters delivered in the consultation
up to 4 months
Secondary Outcomes (2)
The brief version of the World Health Organization quality of life (WHOQOL-BREF)
4 months
The Duke University Religion Index (DUREL) for a brief measure of religiosity that can be included between religion and health outcomes.
4 months
Study Arms (4)
Individual Orientation
EXPERIMENTALThis was a prospective randomized clinical study conducted with the following 4 groups of hypertensive patients: Experimental: individual orientation: receiving individual orientation required by an embracement strategy characterized by 7 nursing visits at 20-day intervals, for 4 months);The ntervention is composed by relational strategies characterized by interpersonal relationships
VLE for Distance Learning
EXPERIMENTALThis was a prospective randomized clinical study conducted with the following 4 groups of hypertensive patients:Experimental: a technological education strategy for distance learning (DL), using a technological education strategy (E-Care of Hypertension) for Distance Learning (DL) characterized by 7 nursing visits at 20-day intervals, for 4 months). The intervention is composed by the use of equipment-oriented techniques or audio-visual aids in educational environments remotely accessed for health education specifically for hypertensive patients
E-blended Learning
EXPERIMENTALThis was a prospective randomized clinical study with the patient received experimental intervention: a technological education strategy with E-blended Learning modality with E-Care of Hypertension, associated with face-to-face consultation with the health professional and making 7 nursing visits at 20-day intervals, for 4 months. The intervention is composed by the use of equipment-oriented techniques or audio-visual aids in presential educational environments intended for health education specifically for hypertensive patients
No intervention
NO INTERVENTIONNo type of intervention was performed making 2 nursing visits at baseline and 1 after 120 days (No intervention)
Interventions
This approach may be individual orientation with by an embracement strategy (relational strategies) may be making 7 nursing visits at 20-day intervals, for 4 month.
Experimental: This approach may be associated with the use of educational technology (E-Care of Hypertension) in a virtual learning environment(VLE) for distance learning (DL) consultation with the health professional and making 7 nursing visits at 20-day intervals, for 4 months
This approach may be associated with the use of educational technology (E-Care of Hypertension) in the blended e-learning mode associated with face-to-face with the health professional and making 7 nursing visits at 20-day intervals, for 4 months
This approach may be individual orientation with conventional therapy may be making 2 nursing visits at baseline and 1 after 120 days,
Eligibility Criteria
You may qualify if:
- Have the medical diagnosis of arterial hypertension,
- Have blood pressure levels equal or above 140 mmHg for systolic blood pressure (SBP), and equal or above 90 mmHg for diastolic blood pressure (DBP),
- Must be able to swallow tablets and under drug treatment with antihypertensives,
- Have digital accessibility through smart phones, tablets or notebooks and PCs.
You may not qualify if:
- Patients with important cognitive impairment will be considered excluded, that is, with poor understanding of simple questions,
- Clinical diagnosis of Alzheimer's disease, or chorea diseases that lead to cognitive impairment such as senile dementia,
- Diagnosis of insulin dependent diabetes. -
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Sao Paulo General Hospitallead
- Luiz Aparecido Bortolottocollaborator
- Chao Lung Wencollaborator
- Margarida Vieiracollaborator
- Miriam Harume Tsunemicollaborator
- Isabela Ribeiro Braga Fistarolcollaborator
- Jefferson Carlos de Oliveiracollaborator
- Dante Marcelo Artiga Giorgicollaborator
- Heno Ferreira Lopescollaborator
- Fernanda Marciano Consolim-Colombocollaborator
- Ivonete Sanches Giacometti Kowalskicollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Masking Details
- Individual Orientation: receiving individual orientation required by an embracement strategy characterized by 7 nursing visits at 20-day intervals, for 4 months);
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 5, 2017
First Posted
October 27, 2017
Study Start
December 18, 2013
Primary Completion
April 25, 2015
Study Completion
February 17, 2017
Last Updated
October 27, 2017
Record last verified: 2017-10
Data Sharing
- IPD Sharing
- Will not share